Haploidentical transplantation combined with mesenchymal stem cells co-infusion improves survival in severe aplastic anemia: a single-center retrospective study

BackgroundHaploidentical hematopoietic stem cell transplantation (HID-HSCT) serves as an alternative treatment for severe aplastic anemia (SAA) patients lacking a suitable HLA-identical sibling donor. Compared to HLA-matched HSCT, HID-HSCT has higher rates of graft failure (GF) and graft-versus-host...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Zhengwei Tan, Miaoya Le, Ningning Zhu, Jingjing Liu, Yuechao Zhao, Huijin Hu, Qinghong Yu, Yu Zhang, Liqiang Wu, Tonglin Hu, Dijiong Wu, Baodong Ye, Wenbin Liu
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Frontiers Media S.A. 2025-11-01
Sarja:	Frontiers in Medicine
Aiheet:	aplastic anemia haploidentical hematopoietic stem cell transplantation mesenchymal stem cells graft-versus-host disease overall survival
Linkit:	https://www.frontiersin.org/articles/10.3389/fmed.2025.1711958/full
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!